Bernhard J. Steinhoff
Hat mitgewirkt an:
-
Long-term efficacy and safety from an open-label extension of adjunctive cenobamate in patients with uncontrolled focal seizures
-
Cenobamate plasma levels in patients with epilepsy : : correlation with efficacy and tolerability?
-
PERPRISE: a prospective non‐interventional study of PERampanel as only adjunctive treatment in patients with PRImary or SEcondarily generalized tonic–clonic seizures: First interim analysis
-
Vademecum Antiepilepticum 2009/2010 : Pharmakotherapie der Eilepsien